PINE Pharmaceuticals to feature new Ophthalmic Compounds at ASCRS•ASOA Symposium & Congress

PINE Pharmaceuticals will feature some of the company’s newest Ophthalmic preparations this weekend at the ASCRS•ASOA Symposium & Congress in Los Angeles.  Representatives will be available to answer questions at exhibit booth #2953 during show hours on Saturday, Sunday and Monday.


In addition to PINE’s widely popular combination drops, TROPIcamide-PHENylephrine and TPC Drops, a wide array of new products will also be on display.  Some of which include dilating agents such as Lidocaine – Epinephrine and antibiotics like Moxifloxacin and Cefuroxime.  Additional information and a full list of products will be available at the PINE exhibit booth as well as special offers for those who place an order at the show.


PINE Pharmaceuticals is an FDA registered & inspected, cGMP compliant, 503B Outsourcing Facility.  All products meet the highest standards industry standards and are available without prescriptions.


The ASCRS•ASOA Symposium & Congress is the largest U.S. meeting that integrates scientific programs with leading practice management programs for comprehensive ophthalmology and sub-specialties.  Attendees will have the opportunity to learn directly from the world’s thought leaders in ophthalmology.